1121169

Surmasis Pharmaceutical, LLC — FEI 3011596846

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 19, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Des Moines, IA (United States)